Quarterly Transactions Made in Black Diamond Therapeutics, Inc. (BDTX)
This table provides information about the institutional ownership of Black Diamond Therapeutics, Inc. (BDTX). The information is specifically focused on institutions that hold shares of Black Diamond Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 588,137 | 1,678,674 | 2,266,811 | 1,854,685 | 286,216 | 2,140,901 | 125,910 | |
| Q4 2021 | 240,585 | 1,222,886 | 1,463,471 | 441,764 | 1,871,329 | 2,313,093 | -849,622 | |
| Q1 2022 | 993,911 | 595,512 | 1,589,423 | 1,110,673 | 885,839 | 1,996,512 | -407,089 | |
| Q2 2022 | 1,707,461 | 1,486,689 | 3,194,150 | 3,560,351 | 663,691 | 4,224,042 | -1,029,892 | |
| Q3 2022 | 876,628 | 437,087 | 1,313,715 | 1,003,698 | 0 | 1,003,698 | 310,017 | |
| Q4 2022 | 1,599,128 | 419,754 | 2,018,882 | 1,889,068 | 0 | 1,889,068 | 129,814 | |
| Q1 2023 | 1,213,916 | 362,498 | 1,576,414 | 932,665 | 0 | 932,665 | 643,749 | |
| Q2 2023 | 8,502,369 | 13,796,125 | 22,298,494 | 847,306 | 0 | 847,306 | 21,451,188 | |
| Q3 2023 | 2,506,001 | 2,573,120 | 5,079,121 | 3,413,164 | 0 | 3,413,164 | 1,665,957 | |
| Q4 2023 | 3,393,795 | 6,794,288 | 10,188,083 | 3,011,873 | 0 | 3,011,873 | 7,176,210 | |
| Q1 2024 | 4,382,463 | 2,582,534 | 6,964,997 | 4,226,228 | 0 | 4,226,228 | 2,738,769 | |
| Q2 2024 | 8,917,288 | 6,433,395 | 15,350,683 | 1,754,934 | 24,500 | 1,779,434 | 13,571,249 | |
| Q3 2024 | 5,271,324 | 3,008,536 | 8,279,860 | 2,779,500 | 0 | 2,779,500 | 5,500,360 | |